John Michael O'Brien retweetledi

Investors across a range of stages, investment sizes, and fund types frequently reported that the #IRA of 2022 is exacerbating challenges in bringing innovative new medicines to market, according to new research in @Health_Affairs at academic.oup.com/healthaffairss… 🧵

English










